indole-3-carbaldehyde has been researched along with Graft-Versus-Host Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Capaldo, C; DeFilipp, Z; Giver, CR; Kalman, D; Powell, D; Qayed, M; Rangaraju, S; Sharma, A; Sonowal, R; Swimm, A; Ulezko Antonova, A; Waller, EK | 1 |
1 other study(ies) available for indole-3-carbaldehyde and Graft-Versus-Host Disease
Article | Year |
---|---|
Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease.
Topics: Allografts; Animals; Bacterial Translocation; Bone Marrow Transplantation; Cytokines; Disease Models, Animal; Escherichia coli; Gastrointestinal Microbiome; Graft vs Host Disease; Indoles; Interferon Type I; Intestinal Mucosa; Mice; Mice, Knockout | 2018 |